Charles Cornish is the Chief Executive Officer for DoseMe, a Tabula Rasa HealthCare (TRHC) subsidiary located in Moorestown, NJ and a regional office in Brisbane, Australia. Charles’ background encompasses more than 20 years in medical devices, pharmaceuticals, healthcare consumables, funds management and management consulting. Mr. Cornish served as Non-Executive (Commercialization) Director at Throat Scope Pty. Ltd., Managing Director at Healthy Holdings, Managing Director at Ontex Australia, Executive at Dalton Nicol Reid, held various positions at Eli Lilly and Company, and served as Senior Manager at KPMG. Charles’ roles have progressed from sales and marketing, strategy, finance through to CEO level and Board seats. These roles have spanned the geographic regions of the United States, Europe, South America, and Australasia. Charles obtained his Bachelor’s Degree in Banking and Finance from Queensland University of Technology, and his Master of Business Administration at University of Melbourne – Melbourne Business School.